92 related articles for article (PubMed ID: 22192782)
1. Evidence-based guideline recommendations on the use of positron emission tomography imaging in colorectal cancer.
Chan K; Welch S; Walker-Dilks C; Raifu A;
Clin Oncol (R Coll Radiol); 2012 May; 24(4):232-49. PubMed ID: 22192782
[TBL] [Abstract][Full Text] [Related]
2. Evidence-based guideline recommendations on the use of positron emission tomography imaging in head and neck cancer.
Yoo J; Henderson S; Walker-Dilks C
Clin Oncol (R Coll Radiol); 2013 Apr; 25(4):e33-66. PubMed ID: 23021712
[TBL] [Abstract][Full Text] [Related]
3. Evidence-based guideline recommendations on the use of positron emission tomography imaging in oesophageal cancer.
Wong R; Walker-Dilks C; Raifu A
Clin Oncol (R Coll Radiol); 2012 Mar; 24(2):86-104. PubMed ID: 21962904
[TBL] [Abstract][Full Text] [Related]
4. The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer.
Pelosi E; Deandreis D
Eur J Surg Oncol; 2007 Feb; 33(1):1-6. PubMed ID: 17126522
[TBL] [Abstract][Full Text] [Related]
5. [18F]FDG PET/CT imaging of colorectal cancer: a pictorial review.
Chowdhury FU; Shah N; Scarsbrook AF; Bradley KM
Postgrad Med J; 2010 Mar; 86(1013):174-82. PubMed ID: 20237012
[TBL] [Abstract][Full Text] [Related]
6. The role of positron emission tomography in the management of recurrent colorectal cancer: a review.
Watson AJ; Lolohea S; Robertson GM; Frizelle FA
Dis Colon Rectum; 2007 Jan; 50(1):102-14. PubMed ID: 17115340
[TBL] [Abstract][Full Text] [Related]
7. [Fluorine-18-2-deoxy-2-fluoro-D-glucose positron emission tomography in colorectal cancer].
Tang G; Kuang A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Feb; 22(1):193-6, 201. PubMed ID: 15762148
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
Potter KC; Husband JE; Houghton SL; Thomas K; Brown G
Dis Colon Rectum; 2009 Feb; 52(2):253-9. PubMed ID: 19279420
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer.
Briggs RH; Chowdhury FU; Lodge JP; Scarsbrook AF
Clin Radiol; 2011 Dec; 66(12):1167-74. PubMed ID: 21867996
[TBL] [Abstract][Full Text] [Related]
10. PET/CT: will it change the way that we use CT in cancer imaging?
Hicks RJ; Ware RE; Lau EW
Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079
[TBL] [Abstract][Full Text] [Related]
11. FDG PET in preoperative assessment of colorectal liver metastases combining "evidence-based practice" and "technology assessment" methods to develop departmental imaging protocols: should FDG PET be routinely used in the preoperative assessment of patients with colorectal liver metastases?
Sheehan JJ; Ridge CA; Ward EV; Duffy GJ; Collins CD; Skehan SJ; Malone DE
Acad Radiol; 2007 Apr; 14(4):389-97. PubMed ID: 17368206
[TBL] [Abstract][Full Text] [Related]
12. [18F-Fluorodeoxyglucose positron emission tomography in restaging of colorectal cancer].
Dietlein M; Weber W; Schwaiger M; Schicha H
Nuklearmedizin; 2003 Aug; 42(4):145-56. PubMed ID: 12937693
[TBL] [Abstract][Full Text] [Related]
13. Utility of 2-fluoro-2-deoxy-D-glucose positron emission tomography in managing patients of colorectal cancer with unexplained carcinoembryonic antigen elevation at different levels.
Liu FY; Chen JS; Changchien CR; Yeh CY; Liu SH; Ho KC; Yen TC
Dis Colon Rectum; 2005 Oct; 48(10):1900-12. PubMed ID: 15991059
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer. Radiologic staging.
Thoeni RF
Radiol Clin North Am; 1997 Mar; 35(2):457-85. PubMed ID: 9087214
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan.
Shen YY; Liang JA; Chen YK; Tsai CY; Kao CH
Hepatogastroenterology; 2006; 53(69):348-50. PubMed ID: 16795969
[TBL] [Abstract][Full Text] [Related]
16. The role of FDG PET/CT in patients with colorectal cancer metastases.
Kochhar R; Liong S; Manoharan P
Cancer Biomark; 2010; 7(4):235-48. PubMed ID: 21576816
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer.
Furukawa H; Ikuma H; Seki A; Yokoe K; Yuen S; Aramaki T; Yamagushi S
Gut; 2006 Jul; 55(7):1007-11. PubMed ID: 16361308
[TBL] [Abstract][Full Text] [Related]
18. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.
Wiering B; Krabbe PF; Jager GJ; Oyen WJ; Ruers TJ
Cancer; 2005 Dec; 104(12):2658-70. PubMed ID: 16315241
[TBL] [Abstract][Full Text] [Related]
19. Preoperative or postoperative therapy for stage II or III rectal cancer: an updated practice guideline.
Wong RK; Berry S; Spithoff K; Simunovic M; Chan K; Agboola O; Dingle B;
Clin Oncol (R Coll Radiol); 2010 May; 22(4):265-71. PubMed ID: 20398849
[TBL] [Abstract][Full Text] [Related]
20. Optimizing the role of FDG PET-CT for potentially operable metastatic colorectal cancer.
Culverwell AD; Chowdhury FU; Scarsbrook AF
Abdom Imaging; 2012 Dec; 37(6):1021-31. PubMed ID: 22371087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
